Monashee Investment Management’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,800
Closed -$2.49M 48
2021
Q3
$2.49M Buy
+3,800
New +$3.25M 0.46% 50

Other funds holding AGL

Monashee Investment Management's AGL Position: Q4 2021 in Review

Monashee Investment Management sold out of Agilon Health (AGL) in Q4 2021, closing a stake of 3,800 shares — an estimated $2.49M sold.

Monashee Investment Management first reported a position in AGL in Q3 2021 and held it in 1 quarter. The position peaked at $2.49M in Q3 2021. 132 funds tracked by Wall St. Rank hold AGL as of Q4 2021.

  • Monashee Investment Management reported no remaining Agilon Health position as of Q4 2021 after selling out during the quarter.
  • Monashee Investment Management sold 3,800 Agilon Health shares in Q4 2021, an estimated $2.49M.
  • Monashee Investment Management first reported a position in Agilon Health in Q3 2021 and held it in 1 quarter.
  • Monashee Investment Management's Agilon Health position peaked at $2.49M in Q3 2021.
  • 132 funds tracked by Wall St. Rank held Agilon Health as of Q4 2021.

Based on Monashee Investment Management's 13F filing for Q4 2021, filed 7 Feb 2022.